Plasma urate and Parkinson's disease in women

American Journal of Epidemiology

Volumn 172, Issue 6, 2010, Pages 666-670

  O'Reilly, Éilis J ^a   Gao, Xiang ^a   Weisskopf, Marc G ^a   Chen, Honglei ^a   Schwarzschild, Michael A ^a   Spiegelman, Donna ^a   Ascherio, Alberto ^a  

^a NONE

Author keywords

case control studies; Parkinson disease; uric acid

Indexed keywords

ACETYLSALICYLIC ACID; CAFFEINE; DIURETIC AGENT; THIAZIDE DIURETIC AGENT; URATE; URIC ACID;

BIOCHEMICAL COMPOSITION; BODY MASS; HEALTH RISK; HORMONE; NERVOUS SYSTEM DISORDER; PLASMA; PUBLIC HEALTH; URINE; WOMENS HEALTH;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; FEMALE; HORMONAL THERAPY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PARKINSON DISEASE; PHYSICAL ACTIVITY; POSTMENOPAUSE; SMOKING; URIC ACID BLOOD LEVEL; BLOOD; DIET; DRINKING BEHAVIOR; EXERCISE; HEALTH STATUS; HORMONE SUBSTITUTION; MIDDLE AGED;

ADULT; AGE FACTORS; ALCOHOL DRINKING; BODY MASS INDEX; DIET; EXERCISE; FEMALE; HEALTH STATUS; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; PARKINSON DISEASE; SMOKING; URIC ACID;

EID: 77956906686     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwq195     Document Type: Article

References (20)

1. Jenner P. Oxidative stress and Parkinsons disease. Handb Clin Neurol. 2007;83:507-520.
2. Davis JW, Grandinetti A, Waslien CI, et al. Observations on serum uric acid levels and the risk of idiopathic Parkinsons disease. Am J Epidemiol. 1996;144(5):480-484.
3. Weisskopf MG, OReilly E, Chen H, et al. Plasma urate and risk of Parkinsons disease. Am J Epidemiol. 2007;166(5): 561-567.
4. de Lau LM, Koudstaal PJ, Hofman A, et al. Serum uric acid levels and the risk of Parkinson disease. Ann Neurol. 2005; 58(5):797-800.
5. Chen H, Mosley TH, Alonso A, et al. Plasma urate and Parkinsons disease in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol. 2009;169(9):1064-1069.
6. De Vera M, Rahman MM, Rankin J, et al. Gout and the risk of Parkinsons disease: a cohort study. Arthritis Rheum. 2008; 59(11):1549-1554.
7. Alonso A, Rodr?́guez LA, Logroscino G, et al. Gout and risk of Parkinson disease: a prospective study. Neurology. 2007; 69(17):1696-1700.
8. Colditz GA, Manson JE, Hankinson SE. The Nurses Health Study: 20-year contribution to the understanding of health among women. J Womens Health. 1997;6(1):49-62.
9. Ascherio A, Zhang SM, Hernán MA, et al. Prospective study of caffeine consumption and risk of Parkinsons disease in men and women. Ann Neurol. 2001;50(1):56-63.
10. Hughes AJ, Daniel SE, Lees AJ. Improved accuracy of clinical diagnosis of Lewy body Parkinsons disease. Neurology. 2001;57(8):1497-1499.
11. Hernán MA, Zhang SM, Rueda-deCastro AM, et al. Cigarette smoking and the incidence of Parkinsons disease in two prospective studies. Ann Neurol. 2001;50(6):780-786.
12. Chen H, OReilly E, McCullough ML, et al. Consumption of dairy products and risk of Parkinsons disease. Am J Epidemiol. 2007;165(9):998-1006.
13. Schwarzschild MA, Schwid SR, Marek K, et al. Serum urate as a predictor of clinical and radiographic progression in Parkinson disease. Arch Neurol. 2008;65(6):716-723.
14. Ascherio A, LeWitt PA, Xu K, et al. Urate as a predictor of the rate of clinical decline in Parkinson disease. Arch Neurol. 2009;66(12):1460-1468.
15. Lotharius J, Brundin P. Pathogenesis of Parkinsons disease: dopamine, vesicles and alpha-synuclein. Nat Rev Neurosci. 2002;3(12):932-942.
16. Duan W, Ladenheim B, Cutler RG, et al. Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinsons disease. J Neurochem. 2002;80(1):101-110.
17. Guerreiro S, Ponceau A, Toulorge D, et al. Protection of midbrain dopaminergic neurons by the end-product of purine metabolism uric acid: potentiation by lowlevel depolarization. J Neurochem. 2009;109(4):1118-1128.
18. Hak AE, Choi HK. Menopause, postmenopausal hormone use and serum uric acid levels in US women-the Third National Health and Nutrition Examination Survey. Arthritis Res Ther. 2008;10(5):R116. (doi:10.1186/ar2519).
19. Ascherio A, Chen H, Schwarzschild MA, et al. Caffeine, postmenopausal estrogen, and risk of Parkinsons disease. Neurology. 2003;60(5):790-795.
20. Ascherio A, Weisskopf MG, OReilly EJ, et al. Coffee consumption, gender, and Parkinsons disease mortality in the Cancer Prevention Study II cohort: the modifying effects of estrogen. Am J Epidemiol. 2004;160(10): 977-984.